ATE340257T1 - Histonedeacetylase 9 - Google Patents

Histonedeacetylase 9

Info

Publication number
ATE340257T1
ATE340257T1 AT02765071T AT02765071T ATE340257T1 AT E340257 T1 ATE340257 T1 AT E340257T1 AT 02765071 T AT02765071 T AT 02765071T AT 02765071 T AT02765071 T AT 02765071T AT E340257 T1 ATE340257 T1 AT E340257T1
Authority
AT
Austria
Prior art keywords
polypeptides
hdac9
histone deacetylase
nucleic acid
disclosed
Prior art date
Application number
AT02765071T
Other languages
German (de)
English (en)
Inventor
Arthur Zelent
Kevin Petrie
Fabien Guidez
Original Assignee
Cancer Res Inst Royal
Arthur Zelent
Kevin Petrie
Fabien Guidez
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Res Inst Royal, Arthur Zelent, Kevin Petrie, Fabien Guidez filed Critical Cancer Res Inst Royal
Application granted granted Critical
Publication of ATE340257T1 publication Critical patent/ATE340257T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT02765071T 2001-10-02 2002-10-02 Histonedeacetylase 9 ATE340257T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0123664.5A GB0123664D0 (en) 2001-10-02 2001-10-02 Histone deacetylase 9

Publications (1)

Publication Number Publication Date
ATE340257T1 true ATE340257T1 (de) 2006-10-15

Family

ID=9923113

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02765071T ATE340257T1 (de) 2001-10-02 2002-10-02 Histonedeacetylase 9

Country Status (7)

Country Link
US (1) US7291492B2 (enExample)
EP (1) EP1432792B1 (enExample)
JP (1) JP4383170B2 (enExample)
AT (1) ATE340257T1 (enExample)
DE (1) DE60214867T2 (enExample)
GB (1) GB0123664D0 (enExample)
WO (1) WO2003029451A2 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1532244A4 (en) 2001-06-14 2005-12-14 Bristol Myers Squibb Co NEW HISTONIC HUMAN DEACETYLASES
US7154002B1 (en) 2002-10-08 2006-12-26 Takeda San Diego, Inc. Histone deacetylase inhibitors
EP1608628A2 (en) 2003-03-17 2005-12-28 Takeda San Diego, Inc. Histone deacetylase inhibitors
GB0321694D0 (en) * 2003-09-16 2003-10-15 Ark Therapeutics Ltd Genes and their therapeutic use
WO2006066133A2 (en) 2004-12-16 2006-06-22 Takeda San Diego, Inc. Histone deacetylase inhibitors
JP2008540574A (ja) 2005-05-11 2008-11-20 タケダ サン ディエゴ インコーポレイテッド ヒストンデアセチラーゼ阻害剤
ZA200800901B (en) 2005-07-14 2010-05-26 Takeda San Diego Inc Histone deacetylase inhibitors
WO2008039461A2 (en) * 2006-09-27 2008-04-03 Thinsilicon Corp. Back contact device for photovoltaic cells and method of manufacturing a back contact
WO2008150769A2 (en) * 2007-05-31 2008-12-11 Thinsilicon Corporation Photovoltaic device and method of manufacturing photovoltaic devices
RU2499599C2 (ru) 2007-09-28 2013-11-27 Интрексон Корпорейшн Конструкции терапевтического переключения генов и биореакторы для экспрессии биотерапевтических молекул и их применение
WO2010011700A2 (en) 2008-07-23 2010-01-28 The Brigham And Women's Hospital, Inc. Treatment of cancers characterized by chromosomal rearrangement of the nut gene
US20100282314A1 (en) * 2009-05-06 2010-11-11 Thinsilicion Corporation Photovoltaic cells and methods to enhance light trapping in semiconductor layer stacks
WO2010144421A2 (en) * 2009-06-10 2010-12-16 Thinsilicon Corporation Photovoltaic modules and methods of manufacturing photovoltaic modules having multiple semiconductor layer stacks
US20110114156A1 (en) * 2009-06-10 2011-05-19 Thinsilicon Corporation Photovoltaic modules having a built-in bypass diode and methods for manufacturing photovoltaic modules having a built-in bypass diode
US11441672B2 (en) * 2019-10-29 2022-09-13 Lokar, Inc. Adjustable shift lever mount

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2393725A1 (en) * 1999-12-08 2001-06-14 Axys Pharmaceuticals, Inc. Histone deacetylase-8 proteins, nucleic acids, and methods of use
AU2002212350A1 (en) * 2000-10-31 2002-05-15 Bayer Aktiengesellschaft Regulation of human histone deacetylase
US20040077046A1 (en) 2000-12-20 2004-04-22 Dalia Cohen Histone deacetylase-related gene and protein
EP1409661A4 (en) 2001-06-14 2006-02-01 Sloan Kettering Inst Cancer HDAC9 POLYPEPTIDES, POLYNUCLEOTIDES AND USES THEREOF
EP1532244A4 (en) 2001-06-14 2005-12-14 Bristol Myers Squibb Co NEW HISTONIC HUMAN DEACETYLASES

Also Published As

Publication number Publication date
JP4383170B2 (ja) 2009-12-16
EP1432792A2 (en) 2004-06-30
DE60214867D1 (en) 2006-11-02
US7291492B2 (en) 2007-11-06
US20050130146A1 (en) 2005-06-16
JP2005503824A (ja) 2005-02-10
WO2003029451A3 (en) 2003-08-21
GB0123664D0 (en) 2001-11-21
WO2003029451A2 (en) 2003-04-10
EP1432792B1 (en) 2006-09-20
DE60214867T2 (de) 2007-05-24

Similar Documents

Publication Publication Date Title
ATE340257T1 (de) Histonedeacetylase 9
NO20031129D0 (no) Varianter av human koagulasjonsfaktor VII
EP1135532A4 (en) Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof
DE60138715D1 (de) Tnf-rezeptor-ähnliche moleküle und deren anwendungen
ATE469911T1 (de) Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
NO961812D0 (no) Humanproteaseinhibitorer av Kunitz-type
WO1998022589A3 (en) Survivin, a protein that inhibits cellular apoptosis, and its modulation
MXPA02012743A (es) Moleculas tipo il-17 y usos de las mismas.
ATE227739T1 (de) Hybridprotein zur hemmung der mastzelldegranulation und dessen verwendung
WO2002014485A3 (en) Kallikrein gene
EA200401453A1 (ru) Молекулы распознавания на клеточной поверхности, содержащие иммуноглобулиновый домен
WO2000053776A3 (en) Human kallikrein-like genes
AUPP472398A0 (en) Protease susceptibility II
AU7303301A (en) Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof
WO2002102316A3 (en) Histone deacetylase and methods of use thereof
ATE310085T1 (de) Cyclin-e2 proteine und dafür kodierende gene
DE60043062D1 (de) Gm-csf aus pferd
BR9910787A (pt) Métodos e composições úteis para modulação deangiogênese usando tirosina cinase src
PL374550A1 (en) Il-17 like molecules and uses thereof
WO2003014340A3 (en) Human histone deacetylase-related gene and protein hdac10
DE60238810D1 (de) Rekombinante D-Hydantoin Hydrolasen und N-Carbamyl-Aminosäure Amid Hydrolasen, dafür kodierende DNA; deren Verwendung zur Herstellung von D-Aminosäuren
DK1005532T3 (da) Isolerede nukleinsyremolekyler kodende for SSX familiemedlemmer og anvendelser deraf
EP1383907A4 (en) ISOLATED HUMAN PROTEASE PROTEINS, HUMAN PROTEASE PROTEINS CODING NUCLEIC ACID MOLECULES, AND USES THEREOF
KR20040053279A (ko) 스트레스 저항성 및 내성 단백질을 코딩하는 유전자
DE60115039D1 (de) Screeningverfahren für modulatoren von methyltransferase abhängiger chromosomenstabilität

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties